“Guest dose unto others as you would have others guest dose unto you.”
I think all opioid treatment program physicians should follow this twist on the Golden Rule.
That is to say, when OTP physicians are contemplating the appropriateness of approving one of our patients to be guest dosed at another OTP, we need to consider whether we would want to be on the receiving end of a similar patient.
What happens if the patient needs to go out of town before they are eligible for these take homes?
There are three options: leave treatment, the worst option, because of the increased risk of death for patients who leave treatment; special take home doses, often risky if the patient isn’t able to take them as prescribed; and guest dosing.
Guest dosing means a patient of one treatment program can be dosed at another program if that patient travels to another area. All opioid treatment programs send their patients for guest dosing and allow guest dosing for patients of other facilities. It should be a smooth and simple process, under ideal circumstances.
But sometimes circumstances get complicated.”
Source: Dr. Jana Burson – March 26, 2018
See Dr. Jana Burson’s blog Physicians’ Decisions to Start Buprenorphine: The Key Factors available at: https://janaburson.wordpress.com/2018/03/11/physicians-decisions-to-start-buprenorphine-the-key-factors/